| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Carcinogenesis and Molecular Epidemiology, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595
The purpose of this study is to evaluate the efficacy of three promising sulfur-containing compounds, 6-phenylhexyl isothiocyanate (PHITC), phenethyl isothiocyanate (PEITC), and N-acetylcysteine (NAC), as chemopreventive agents in a long-term bioassay for lung tumorigenesis in F344 rats. PEITC occurs as a constituent of certain cruciferous vegetables, PHITC is a synthetic homologue, and NAC is an endogenous substance. Male F344 rats were treated with the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by s.c. injection at a dose of 1.5 mg/kg body weight three times weekly for 20 weeks. This dose regimen induced a 67% tumor incidence in the lung, a major target organ of NNK. PHITC or PEITC administered in the diet for 22 weeks, a period covering from 1 week before to 1 week after the NNK treatment, exhibited significant inhibition of lung tumorigenesis induced by NNK. The lung tumor incidences in the NNK-treated groups, fed a diet containing 4 mmol/kg (876 ppm) or 2 mmol/kg (438 ppm) PHITC, were 24 and 19% and were 9 and 17% in groups fed PEITC at concentrations of 8 mmol/kg (1304 ppm) or 4 mmol/kg (652 ppm), respectively. In contrast to isothiocyanates, NAC given in the diet at 80 mmol/kg (13056 ppm) or 40 mmol/kg (6528 ppm) exerted no inhibitory effects on the NNK-induced lung tumorigenesis. At the dose studied, NNK did not induce liver and pancreatic tumors in the treated animals, but a significant increase of nasal cavity tumor incidence was observed in the NNK-treated group. However, none of the test compounds showed any effect on the tumorigenesis in this tissue. This study demonstrated that PHITC and PEITC were potent chemopreventive agents for the NNK-induced lung tumorigenesis in F344 rats, whereas NAC was not active at all. These results support further evaluation of these compounds in chemoprevention studies.
1 This work was supported by a Master Agreement Order No. N01-85096-06 from the Division of Cancer Prevention and Control of the National Cancer Institute. This is Paper 22 in the series. "Dietary Inhibitors of Chemical Carcinogenesis."
2 To whom requests for reprints should be addressed, at American Health Foundation, One Dana Road, Valhalla, NY 10595.
Received 9/28/95. Accepted 12/15/95.
This article has been cited by other articles:
![]() |
F. Kassie, I. Matise, M. Negia, D. Lahti, Y. Pan, R. Scherber, P. Upadhyaya, and S. S. Hecht Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen-Induced Lung Adenocarcinoma in Mice Cancer Prevention Research, September 1, 2008; 1(4): 285 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice Cancer Res., September 15, 2005; 65(18): 8548 - 8557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boysen, P. M.J. Kenney, P. Upadhyaya, M. Wang, and S. S. Hecht Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats Carcinogenesis, March 1, 2003; 24(3): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, P. Upadhyaya, M. Wang, R. L. Bliss, E. J. McIntee, and P. M.J. Kenney Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination Carcinogenesis, September 1, 2002; 23(9): 1455 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Seril, J. Liao, K.-L. K. Ho, C. S. Yang, and G.-Y. Yang Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine Carcinogenesis, June 1, 2002; 23(6): 993 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points Carcinogenesis, July 1, 2001; 22(7): 999 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Izzotti, R. M. Balansky, F. DAgostini, C. Bennicelli, S. R. Myers, C. J. Grubbs, R. A. Lubet, G. J. Kelloff, and S. De Flora Modulation of Biomarkers by Chemopreventive Agents in Smoke-exposed Rats Cancer Res., March 1, 2001; 61(6): 2472 - 2479. [Abstract] [Full Text] |
||||
![]() |
F.-L. Chung, C.C. Conaway, C.V. Rao, and B. S. Reddy Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate Carcinogenesis, December 1, 2000; 21(12): 2287 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, and S. E. Murphy Effects of Watercress Consumption on Urinary Metabolites of Nicotine in Smokers Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 907 - 913. [Abstract] [Full Text] |
||||
![]() |
Prevention of Cancer in the Next Millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research Cancer Res., October 1, 1999; 59(19): 4743 - 4758. [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Chemoprevention of Cancer by Isothiocyanates, Modifiers of Carcinogen Metabolism J. Nutr., March 1, 1999; 129(3): 768 - 768. [Abstract] [Full Text] |
||||
![]() |
S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni, and J. M. Phang Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice J Natl Cancer Inst, February 3, 1999; 91(3): 215 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Conaway, D. Jiao, T. Kohri, L. Liebes, and F.-L. Chung Disposition and Pharmacokinetics of Phenethyl Isothiocyanate and 6-Phenylhexyl Isothiocyanate in F344 Rats Drug Metab. Dispos., January 1, 1999; 27(1): 13 - 20. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |